United States · Bill · HR
H.R. 1026 (117th)
LABEL Opioids Act
Introduced
11 February 2021
Last action
—
Status
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Sponsors
—
Subjects
Discovery layer
Source updated
6 December 2025
Summary
Lessening Addiction By Enhancing Labeling Opioids Act of 2021 or the LABEL Opioids Act This bill requires prescription opioids to contain a warning label specifying that the opioids may cause dependence, addiction, and overdose. A registrant (e.g., a pharmacist) who dispenses an opioid in violation of the labeling requirement is subject to penalties.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 11 February 2021
Introduced in House (PDF)
Introduced in House · EN · 11 February 2021
Introduced in House
summary · EN · 11 February 2021
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/117th-congress/house-bill/1026
- Open data entity: https://api.congress.gov/v3/bill/117/hr/1026